Fourth Sail Capital LP Acquires 928,708 Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Key Points

• Fourth Sail Capital LP increased its stake in Bioceres Crop Solutions Corp. by 25.1% in Q1, owning approximately 4.6 million shares valued at $21.13 million, making it the fund's 8th largest position.
• Several institutional investors have also recently increased their holdings in Bioceres, with 17.68% of the stock now owned by institutional investors.
• Wall Street analysts have mixed views on Bioceres, with one downgrading the stock to a "sell" and another decreasing its target price from $7.00 to $6.00, while the overall consensus rating remains a "Moderate Buy".

Fourth Sail Capital LP grew its stake in shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) by 25.1% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,627,669 shares of the company's stock after buying an additional 928,708 shares during the period. Bioceres Crop Solutions accounts for 4.9% of Fourth Sail Capital LP's portfolio, making the stock its 8th biggest holding. Fourth Sail Capital LP owned 7.38% of Bioceres Crop Solutions worth $21,125,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. Bank of America Corp DE increased its stake in Bioceres Crop Solutions by 186.8% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock worth $35,000 after acquiring an additional 3,735 shares during the last quarter. Jump Financial LLC purchased a new position in shares of Bioceres Crop Solutions in the fourth quarter valued at $72,000. Ping Capital Management Inc. increased its position in Bioceres Crop Solutions by 29.5% in the first quarter. Ping Capital Management Inc. now owns 57,000 shares of the company's stock worth $260,000 after purchasing an additional 13,000 shares during the last quarter. JPMorgan Chase & Co. increased its position in Bioceres Crop Solutions by 17.0% in the fourth quarter. JPMorgan Chase & Co. now owns 105,301 shares of the company's stock worth $640,000 after purchasing an additional 15,328 shares during the last quarter. Finally, Northern Trust Corp purchased a new stake in Bioceres Crop Solutions during the fourth quarter valued at $93,000. 17.68% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms recently commented on BIOX. Oppenheimer dropped their price target on Bioceres Crop Solutions from $7.00 to $6.00 and set an "outperform" rating for the company in a research report on Tuesday, July 15th. Wall Street Zen lowered Bioceres Crop Solutions from a "hold" rating to a "sell" rating in a research note on Sunday, August 3rd. One investment analyst has rated the stock with a sell rating and four have assigned a buy rating to the stock. According to MarketBeat, Bioceres Crop Solutions presently has a consensus rating of "Moderate Buy" and a consensus target price of $8.38.

Bioceres Crop Solutions Stock Down 6.6%

Bioceres Crop Solutions stock traded down $0.22 during midday trading on Friday, reaching $3.10. The company's stock had a trading volume of 178,874 shares, compared to its average volume of 203,040. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.02 and a quick ratio of 0.74. The stock has a market capitalization of $194.40 million, a P/E ratio of -22.14, a PEG ratio of 1.44 and a beta of 0.44. The stock's 50-day simple moving average is $4.28 and its 200-day simple moving average is $4.64. Bioceres Crop Solutions Corp. has a 52-week low of $3.00 and a 52-week high of $11.41.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last announced its quarterly earnings data on Wednesday, May 21st. The company reported ($0.02) earnings per share for the quarter, beating analysts' consensus estimates of ($0.10) by $0.08. The firm had revenue of $59.60 million for the quarter, compared to analyst estimates of $61.80 million. Bioceres Crop Solutions had a negative net margin of 2.14% and a negative return on equity of 2.37%. On average, sell-side analysts expect that Bioceres Crop Solutions Corp. will post -0.05 EPS for the current year.

Bioceres Crop Solutions Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.